{"id":31724,"date":"2019-02-12T12:00:00","date_gmt":"2019-02-12T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita\/"},"modified":"2019-02-12T12:00:00","modified_gmt":"2019-02-12T12:00:00","slug":"cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/es\/news\/cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita\/","title":{"rendered":"\u00bfCu\u00e1les son los retos u oportunidades para la adopci\u00f3n de la ITA?"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1439 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<h2>Rhinology Future Debates Bruselas 2018<\/h2>\n<p>En este v\u00eddeo, nuestros panelistas analizan la adopci\u00f3n de la inmunoterapia con al\u00e9rgenos mediante la implementaci\u00f3n de estrategias de gesti\u00f3n del cambio, dado que la inmunoterapia con al\u00e9rgenos es altamente eficaz en la rinitis al\u00e9rgica y el asma. Conozca las barreras u oportunidades en la adopci\u00f3n de esta terapia. <\/p>\n<h3>Panelistas<\/h3>\n<p>Claus Bachert, Jean Bousquet, Mohamed Shamji, Walter Canonica, representante de pacientes de ITA.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1440 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"Reproductor de v\u00eddeo de YouTube\" src=\"https:\/\/www.youtube.com\/embed\/mmEs-ju-OSQ?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Rhinology Future Debates Bruselas 2018 En este v\u00eddeo, nuestros panelistas analizan la adopci\u00f3n de la inmunoterapia con al\u00e9rgenos mediante la implementaci\u00f3n de estrategias de gesti\u00f3n del cambio, dado que la inmunoterapia con al\u00e9rgenos es altamente eficaz en la rinitis al\u00e9rgica y el asma. Conozca las barreras u oportunidades en la adopci\u00f3n de esta terapia. Panelistas Claus Bachert, Jean Bousquet, Mohamed Shamji, Walter Canonica, representante de pacientes de ITA.<\/p>\n","protected":false},"author":1,"featured_media":31743,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[202],"tags":[203,205,206],"class_list":["post-31724","news","type-news","status-publish","has-post-thumbnail","hentry","category-debates-futuros-de-rinologia","tag-rinologia","tag-debates","tag-debates-futuros-de-rinologia"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.3 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>\u00bfCu\u00e1les son los retos u oportunidades para la adopci\u00f3n de la ITA? - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/es\/news\/cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00bfCu\u00e1les son los retos u oportunidades para la adopci\u00f3n de la ITA?\" \/>\n<meta property=\"og:description\" content=\"Rhinology Future Debates Bruselas 2018 En este v\u00eddeo, nuestros panelistas analizan la adopci\u00f3n de la inmunoterapia con al\u00e9rgenos mediante la implementaci\u00f3n de estrategias de gesti\u00f3n del cambio, dado que la inmunoterapia con al\u00e9rgenos es altamente eficaz en la rinitis al\u00e9rgica y el asma. Conozca las barreras u oportunidades en la adopci\u00f3n de esta terapia. Panelistas Claus Bachert, Jean Bousquet, Mohamed Shamji, Walter Canonica, representante de pacientes de ITA.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/es\/news\/cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita\\\/\",\"name\":\"\u00bfCu\u00e1les son los retos u oportunidades para la adopci\u00f3n de la ITA? - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_3.png\",\"datePublished\":\"2019-02-12T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita\\\/#breadcrumb\"},\"inLanguage\":\"es-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es-ES\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_3.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_3.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/elige-tu-camino\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"\u00bfCu\u00e1les son los retos u oportunidades para la adopci\u00f3n de la ITA?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es-ES\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-ES\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u00bfCu\u00e1les son los retos u oportunidades para la adopci\u00f3n de la ITA? - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/es\/news\/cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita\/","og_locale":"es_ES","og_type":"article","og_title":"\u00bfCu\u00e1les son los retos u oportunidades para la adopci\u00f3n de la ITA?","og_description":"Rhinology Future Debates Bruselas 2018 En este v\u00eddeo, nuestros panelistas analizan la adopci\u00f3n de la inmunoterapia con al\u00e9rgenos mediante la implementaci\u00f3n de estrategias de gesti\u00f3n del cambio, dado que la inmunoterapia con al\u00e9rgenos es altamente eficaz en la rinitis al\u00e9rgica y el asma. Conozca las barreras u oportunidades en la adopci\u00f3n de esta terapia. Panelistas Claus Bachert, Jean Bousquet, Mohamed Shamji, Walter Canonica, representante de pacientes de ITA.","og_url":"https:\/\/www.euforea.org\/es\/news\/cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","twitter_card":"summary_large_image","twitter_site":"@euforea","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/es\/news\/cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita\/","url":"https:\/\/www.euforea.org\/es\/news\/cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita\/","name":"\u00bfCu\u00e1les son los retos u oportunidades para la adopci\u00f3n de la ITA? - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/es\/news\/cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/es\/news\/cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_3.png","datePublished":"2019-02-12T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/es\/news\/cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita\/#breadcrumb"},"inLanguage":"es-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/es\/news\/cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita\/"]}]},{"@type":"ImageObject","inLanguage":"es-ES","@id":"https:\/\/www.euforea.org\/es\/news\/cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_3.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_3.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/es\/news\/cuales-son-los-retos-u-oportunidades-para-la-adopcion-de-la-ita\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/www.euforea.org\/es\/elige-tu-camino\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/es\/news\/"},{"@type":"ListItem","position":3,"name":"\u00bfCu\u00e1les son los retos u oportunidades para la adopci\u00f3n de la ITA?"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/es\/#website","url":"https:\/\/www.euforea.org\/es\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es-ES"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/es\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es-ES","@id":"https:\/\/www.euforea.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/news\/31724","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/comments?post=31724"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/news\/31724\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/media\/31743"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/media?parent=31724"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/categories?post=31724"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/tags?post=31724"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}